title: On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia.
authors.forename: F
authors.initials: F
authors.lastname: Lo Coco
authors.forename: D
authors.initials: D
authors.lastname: Diverio
authors.forename: G
authors.initials: G
authors.lastname: Avvisati
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: A
authors.initials: A
authors.lastname: Biondi
authors.forename: P G
authors.initials: PG
authors.lastname: Pelicci
mesh_terms: D014408:Biomarkers, Tumor; D002454:Cell Differentiation / Q000187:drug effects; D015321:Gene Rearrangement; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000473:pathology / Q000628:therapy*; D009363:Neoplasm Proteins / Q000187:drug effects / Q000235:genetics; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology; D018168:Receptors, Retinoic Acid / Q000187:drug effects / Q000235:genetics; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D009363:Neoplasm Proteins; C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin